Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
XXII | US
0.00
0.10%
Healthcare
Biotechnology
30/06/2024
21/10/2024
0.10
0.10
0.11
0.10
22nd Century Group Inc. an agricultural biotechnology company focuses on tobacco harm reduction reduced nicotine tobacco and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical therapeutic and agricultural uses as well as other applications. 22nd Century Group Inc. was founded in 1998 and is headquartered in Buffalo New York.
View LessStrength based on increasing price with high volume
Low Debt to Equity (< 0.25)
Value Stock (Price to Book < 3)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
125.0%1 month
135.3%3 months
133.3%6 months
116.8%-
-
0.38
-10.72
0.43
-0.47
0.39
-
-27.08M
3.30M
3.30M
-
-25.76
-
-1.30
-105.57
0.02
1.04
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.11
Range1M
0.22
Range3M
0.75
Rel. volume
1.16
Price X volume
469.79K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Virpax Pharmaceuticals Inc | VRPX | Biotechnology | 0.7216 | 3.53M | 6.15% | n/a | 0.00% |
Biodexa Pharmaceticals | BDRX | Biotechnology | 5.98 | 3.47M | 4.91% | n/a | 0.00% |
Alaunos Therapeutics Inc | TCRT | Biotechnology | 2.16 | 3.46M | -4.42% | n/a | 0.00% |
QNRX | QNRX | Biotechnology | 0.8646 | 3.44M | 1.72% | n/a | 43.11% |
Aptevo Therapeutics Inc | APVO | Biotechnology | 0.2389 | 3.21M | 20.35% | n/a | 112.59% |
Galera Therapeutics Inc | GRTX | Biotechnology | 0.0555 | 3.07M | 2.78% | n/a | -0.87% |
NovaBay Pharmaceuticals Inc | NBY | Biotechnology | 0.6211 | 3.03M | -1.38% | n/a | -325.77% |
Hiru Corporation | HIRU | Biotechnology | 0.0016 | 3.02M | -15.79% | n/a | 263.27% |
SciSparc Ltd. Ordinary Shares | SPRC | Biotechnology | 0.29 | 3.00M | 26.53% | n/a | 1.00% |
Ensysce Biosciences Inc | ENSC | Biotechnology | 0.206 | 2.86M | 15.86% | n/a | 24.79% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Forza X1 Inc | FRZA | Recreational Vehicles | 0.19 | 2.99M | -13.68% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.06 | 2.71M | 0.00% | n/a | 17.32% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 3.65 | 2.01M | -6.89% | n/a | 0.00% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.011 | 1.01M | 10.00% | n/a | -37.05% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -0.47 | 0.53 | Cheaper |
Ent. to Revenue | 0.39 | 3,967.00 | Cheaper |
PE Ratio | - | 41.03 | - |
Price to Book | 0.38 | 15.55 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 133.34 | 72.80 | Riskier |
Debt to Equity | -10.72 | -1.23 | Cheaper |
Debt to Assets | 0.43 | 0.25 | Expensive |
Market Cap | 3.30M | 3.66B | Emerging |